FNA Stock Price, Paragon 28, Inc. Quote, Chart

Market Summary

USD9.64-0.41

Market Closed

-4.08%

FNA Alerts

1 major insider buys recently.

FNA Stock Price

View Fullscreen

FNA RSI Chart

FNA Valuation

Market Cap

832.5M

Price/Earnings (Trailing)

-17.4

Price/Sales (Trailing)

3.85

EV/EBITDA

-32.19

Price/Free Cashflow

-13.03

FNA Price/Sales (Trailing)

FNA Profitability

Operating Margin

79.85%

EBT Margin

-22.01%

Return on Equity

-26.92%

Return on Assets

-14.04%

Free Cashflow Yield

-7.67%

FNA Fundamentals

FNA Revenue

Revenue (TTM)

216.4M

Rev. Growth (Yr)

17.58%

Rev. Growth (Qtr)

14.74%

FNA Earnings

Earnings (TTM)

-47.8M

Earnings Growth (Yr)

49.54%

Earnings Growth (Qtr)

-134.75%

Breaking Down FNA Revenue

Last 7 days

4.3%

Last 30 days

6.8%

Last 90 days

-17.6%

Trailing 12 Months

-43.1%

How does FNA drawdown profile look like?

FNA Financial Health

Current Ratio

4.21

Debt/Equity

0.62

Debt/Cashflow

-0.58

FNA Investor Care

Shares Dilution (1Y)

7.23%

Diluted EPS (TTM)

-0.57

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	192.0M	200.6M	207.3M	216.4M
2022	155.7M	162.5M	172.7M	181.4M
2021	120.1M	129.2M	138.3M	147.5M
2020	0	0	108.6M	111.0M
2019	0	0	0	106.3M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Paragon 28, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 15, 2024	dacosta albert	bought	255,226	9.1152	28,000	see remarks
Mar 08, 2024	dacosta albert	acquired	-	-	166,924	see remarks
Mar 08, 2024	deitsch stephen	acquired	-	-	108,346	chief financial officer
Mar 08, 2024	mickelson erik e	acquired	-	-	15,455	chief accounting officer
Mar 08, 2024	mccormack robert s	acquired	-	-	71,483	see remarks
Mar 08, 2024	jarboe matthew	acquired	-	-	98,454	chief commercial officer
Feb 28, 2024	mickelson erik e	sold (taxes)	-11,226	12.15	-924	chief accounting officer
Feb 28, 2024	jarboe matthew	sold (taxes)	-39,876	12.15	-3,282	chief commercial officer
Feb 28, 2024	deitsch stephen	sold (taxes)	-43,897	12.15	-3,613	chief financial officer
Feb 28, 2024	dacosta albert	sold (taxes)	-115,060	12.15	-9,470	see remarks

Which funds bought or sold FNA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	reduced	-74.74	-59,000	20,000	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	-3,008	311,533	-%
Apr 19, 2024	Valeo Financial Advisors, LLC	unchanged	-	-12,200	1,883,310	0.06%
Apr 19, 2024	Park Edge Advisors, LLC	unchanged	-	-46,651	7,201,820	2.01%
Apr 16, 2024	MCF Advisors LLC	sold off	-100	-2,598	-	-%
Apr 05, 2024	CWM, LLC	reduced	-11.15	-2,000	15,000	-%
Mar 22, 2024	PNC FINANCIAL SERVICES GROUP, INC.	new	-	24,885	24,885	-%
Mar 11, 2024	VANGUARD GROUP INC	added	2.43	364,814	25,486,000	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	338	3,789,070	4,923,350	-%
Feb 28, 2024	AMERICAN INTERNATIONAL GROUP, INC.	reduced	-0.4	-3,724	271,347	-%

Are Funds Buying or Selling FNA?

Are funds buying FNA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own FNA

No. of Funds

FNA Alerts

1 major insider buys recently.

Unveiling Paragon 28, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	dacosta albert	14.2%	11,832,644	SC 13G/A
Feb 13, 2024	mvm partners, llc	13.2%	10,886,145	SC 13G/A
Feb 14, 2023	mvm partners, llc	17.7%	13,659,625	SC 13G/A
Feb 13, 2023	rosenthal investment company, llc	9.4%	7,214,165	SC 13G/A
Feb 13, 2023	dacosta albert	16.6%	12,782,924	SC 13G/A
Jan 12, 2023	bird b. ag	20.2%	15,551,180	SC 13G
Jul 29, 2022	rosenthal investment company, llc	9.4%	7,214,165	SC 13G
Feb 11, 2022	dacosta albert	15.9%	12,238,500	SC 13G
Feb 09, 2022	mvm partners llp	18.9%	14,414,195	SC 13G

Recent SEC filings of Paragon 28, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 05, 2024	DEF 14A	DEF 14A
Apr 05, 2024	DEFA14A	DEFA14A
Apr 04, 2024	8-K	Current Report
Mar 18, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	3	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading

Peers (Alternatives to Paragon 28, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	185.5B	40.1B	-2.69%	-2.54%	32.41	4.63	-8.12%	-17.45%
BDX	67.5B	19.5B	-4.86%	-10.59%	53.77	3.46	4.02%	-22.04%
ALGN	23.6B	3.9B	-2.36%	-14.10%	52.95	6.1	3.42%	23.09%
BAX	20.8B	14.8B	-2.22%	-9.67%	7.83	1.4	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	-0.49%	-14.47%	22.62	0.76	-2.44%	-22.68%
ATR	9.3B	3.5B	-1.02%	16.40%	32.52	2.65	4.97%	18.89%
BIO	8.1B	2.7B	-18.63%	-38.25%	-12.74	3.04	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.77%	-25.53%	-47.67	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-2.62%	10.65%	-558.61	9.25	33.86%	89.83%
PDCO	2.3B	6.6B	-4.73%	-4.84%	12.02	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-11.22%	-19.13%	-1.92	0.41	7.73%	-1066.14%
ANIK	383.0M	166.7M	1.30%	-3.37%	-4.63	2.3	6.67%	-456.34%
ANGO	241.5M	324.0M	12.50%	-31.24%	-1.26	0.75	-3.19%	-337.41%
APYX	45.7M	52.3M	5.60%	-56.15%	-2.44	0.87	17.61%	19.28%
AEMD	4.0M	3.7M	-11.70%	184.91%	-0.32	1.06	5.77%	8.23%

Paragon 28, Inc. News

Latest updates

Paragon 28, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)															(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Revenue	14.7%	60,561,000	52,783,000	51,009,000	52,036,000	51,508,000	46,006,000	42,498,000	41,371,000	42,775,000	35,851,000	35,734,000	33,104,000	31,686,000	30,268,000	-
Cost Of Revenue	48.5%	15,440,000	10,394,000	8,858,000	8,906,000	9,537,000	8,491,000	7,638,000	6,791,000	7,815,000	7,096,000	6,672,000	6,441,000	-	7,049,000	-
Gross Profit	6.4%	45,121,000	42,389,000	42,151,000	43,130,000	41,971,000	37,515,000	34,860,000	34,580,000	34,960,000	28,755,000	29,062,000	26,663,000	-	23,219,000	-
Operating Expenses	9.7%	56,351,000	51,370,000	51,510,000	50,869,000	78,016,000	46,004,000	43,938,000	43,015,000	39,952,000	33,086,000	30,232,000	26,945,000	-	19,304,000	-
S&GA Expenses	9.3%	48,249,000	44,126,000	43,827,000	43,820,000	44,466,000	39,667,000	37,948,000	37,242,000	35,078,000	28,968,000	26,645,000	23,396,000	-	16,958,000	-
R&D Expenses	11.8%	8,102,000	7,244,000	7,683,000	7,049,000	6,550,000	6,337,000	5,990,000	5,773,000	4,874,000	4,118,000	3,587,000	3,549,000	-	2,346,000	-
EBITDA Margin	46.5%	-0.12	-0.23	-0.25	-0.25	-0.27	-0.11	-0.09	-0.06	-0.02	0.06	0.11	0.10	0.11	0.06	-
Interest Expenses	82.1%	2,038,000	1,119,000	803,000	1,205,000	1,264,000	1,093,000	1,104,000	668,000	545,000	573,000	537,000	64,000	-	70,000	-
Income Taxes	213.9%	123,000	-108,000	269,000	-71,000	-370,000	201,000	73,000	32,000	276,000	105,000	178,000	154,000	-	-19,000	-
Earnings Before Taxes	-130.3%	-19,436,000	-8,440,000	-10,629,000	-9,123,000	-39,133,000	-9,523,000	-9,530,000	-9,204,000	-5,899,000	-5,002,000	-1,706,000	-373,000	-	3,789,000	-
EBT Margin	32.2%	-0.22	-0.32	-0.34	-0.35	-0.37	-0.20	-0.18	-0.14	-0.09	-0.01	0.06	0.04	0.05	0.02	-
Net Income	-134.7%	-19,559,000	-8,332,000	-10,898,000	-9,052,000	-38,763,000	-9,724,000	-9,603,000	-9,236,000	-6,175,000	-5,107,000	-1,884,000	-527,000	-	3,808,000	-
Net Income Margin	31.6%	-0.22	-0.32	-0.34	-0.35	-0.37	-0.20	-0.19	-0.14	-0.09	-0.02	0.04	0.03	0.03	0.03	-
Free Cashflow	-16.0%	-16,373,000	-14,114,000	-27,176,000	-21,581,000	-19,399,000	-18,279,000	-39,510,000	-13,533,000	-10,147,000	-8,815,000	-3,304,000	653,000	3,006,000	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet												(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2020Q4	2020Q3
Assets	16.1%	341	293	301	314	254	257	265	269	235	122	98.00	98.00
Current Assets	27.9%	216	169	180	197	142	150	161	169	180	72.00	72.00	-
Cash Equivalents	116.4%	76.00	35.00	57.00	86.00	38.00	56.00	73.00	94.00	109	8.00	18.00	18.00
Inventory	3.9%	98.00	94.00	85.00	69.00	61.00	55.00	52.00	43.00	40.00	38.00	32.00	-
Net PPE	0.8%	74.00	74.00	71.00	67.00	62.00	59.00	56.00	52.00	32.00	26.00	22.00	-
Goodwill	0%	25.00	25.00	25.00	25.00	25.00	27.00	27.00	27.00	19.00	7.00	-	-
Liabilities	63.6%	163	100	102	108	113	86.00	88.00	84.00	42.00	55.00	26.00	-
Current Liabilities	-6.7%	51.00	55.00	56.00	64.00	69.00	42.00	44.00	38.00	34.00	29.00	22.00	-
Long Term Debt	159.6%	110	42.00	42.00	42.00	42.00	42.00	43.00	42.00	7.00	23.00	4.00	-
LT Debt, Current	0%	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	2.00	-
LT Debt, Non Current	159.6%	110	42.00	42.00	42.00	42.00	42.00	43.00	42.00	7.00	23.00	4.00	-
Shareholder's Equity	-8.3%	178	194	199	205	141	171	177	185	192	24.00	30.00	24.00
Retained Earnings	-20.4%	-115	-96.07	-87.74	-76.84	-67.79	-29.03	-19.30	-9.70	-0.46	3.00	12.00	-
Additional Paid-In Capital	0.8%	298	296	292	287	214	207	202	200	198	26.00	22.00	-
Shares Outstanding	0.3%	83.00	83.00	83.00	82.00	78.00	77.00	76.00	76.00	53.00	47.00	44.00	43.00
Float	-	-	-	831	-	-	-	521	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)															(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Cashflow From Operations	-16.0%	-16,373	-14,114	-19,343	-14,060	-13,231	-12,111	-33,342	9,503	-2,121	-5,062	180	3,686	-	-	-
Share Based Compensation	-41.1%	2,070	3,512	3,600	3,182	3,313	2,587	2,343	2,122	2,201	1,032	857	858	-	-	-
Cashflow From Investing	26.8%	-4,956	-6,768	-7,711	-7,552	-7,174	-5,547	-6,336	-41,636	-9,605	-3,911	-18,959	-3,015	-	-	-
Cashflow From Financing	4776.0%	63,173	-1,351	-2,536	69,367	2,550	1,220	147	35,570	113,300	1,083	16,735	-22.00	-	-	-
Buy Backs	-	-	-	-	-	-	-	266	-	-	-	-	561	-	-	-

FNA Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Net revenue	$ 216,389	$ 181,383	$ 147,464
Cost of goods sold	43,598	32,457	28,024
Gross profit	172,791	148,926	119,440
Operating expenses
Research and development costs	30,078	24,650	16,128
Selling, general, and administrative	180,022	159,323	114,087
Legal settlement		27,000
Total operating expenses	210,100	210,973	130,215
Operating loss	(37,309)	(62,047)	(10,775)
Other income (expense):
Other income (expense)	154	(1,214)	(486)
Loss on early extinguishment of debt	(5,308)
Interest expense, net	(5,165)	(4,129)	(1,719)
Total other expense	(10,319)	(5,343)	(2,205)
Loss before income taxes	(47,628)	(67,390)	(12,980)
Income tax expense (benefit)	213	(64)	713
Net loss	(47,841)	(67,326)	(13,693)
Foreign currency translation adjustment	165	(41)	(815)
Comprehensive loss	$ (47,676)	$ (67,367)	$ (14,508)
Weighted average number of shares of common stock outstanding:
Basic	82,087,329	76,766,100	52,916,711
Diluted	82,087,329	76,766,100	52,916,711
Net loss per share attributable to common stockholders:
Basic	$ (0.58)	$ (0.88)	$ (0.26)
Diluted	$ (0.58)	$ (0.88)	$ (0.26)

FNA Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 75,639	$ 38,468
Trade receivables	37,323	37,687
Inventories, net	98,062	60,948
Income taxes receivable	794	615
Other current assets	3,997	4,658
Total current assets	215,815	142,376
Property and equipment, net	74,122	61,938
Intangible assets, net	21,674	22,387
Goodwill	25,465	25,465
Deferred income taxes	705	148
Other assets	2,918	1,795
Total assets	340,699	254,109
Current liabilities:
Accounts payable	21,696	14,939
Accrued expenses	27,781	26,807
Accrued legal settlement		22,000
Other current liabilities	883	3,844
Current maturities of long-term debt	640	728
Income taxes payable	243	184
Total current liabilities	51,243	68,502
Long-term liabilities:
Long-term debt net, less current maturities	109,799	42,182
Other long-term liabilities	1,048	1,628
Deferred income taxes	233	342
Income taxes payable	635	527
Total liabilities	162,958	113,181
Commitments and contingencies (Note 14)
Stockholders' equity:
Common stock, $0.01 par value, 300,000,000 shares authorized; 83,738,974 and 78,684,107 shares issued, and 82,825,455 and 77,770,588 shares outstanding as of December 31, 2023 and December 31, 2022, respectively	827	776
Additional paid in capital	298,394	213,956
Accumulated deficit	(115,630)	(67,789)
Accumulated other comprehensive income (loss)	132	(33)
Treasury stock, at cost; 913,519 shares as of December 31, 2023 and December 31, 2022	(5,982)	(5,982)
Total stockholders' equity	177,741	140,928
Total liabilities & stockholders' equity	$ 340,699	$ 254,109

About Paragon 28, Inc.

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

CEO	Mr. Albert DaCosta
WEBSITE	paragon28.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	463

Paragon 28, Inc. Frequently Asked Questions

What is the ticker symbol for Paragon 28, Inc.? What does FNA stand for in stocks?

FNA is the stock ticker symbol of Paragon 28, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Paragon 28, Inc. (FNA)?

As of Tue Apr 23 2024, market cap of Paragon 28, Inc. is 832.51 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of FNA stock?

You can check FNA's fair value in chart for subscribers.

What is the fair value of FNA stock?

You can check FNA's fair value in chart for subscribers. The fair value of Paragon 28, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Paragon 28, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for FNA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Paragon 28, Inc. a good stock to buy?

The fair value guage provides a quick view whether FNA is over valued or under valued. Whether Paragon 28, Inc. is cheap or expensive depends on the assumptions which impact Paragon 28, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FNA.

What is Paragon 28, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, FNA's PE ratio (Price to Earnings) is -17.4 and Price to Sales (PS) ratio is 3.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FNA PE ratio will change depending on the future growth rate expectations of investors.